Kalogon raises funding
By HME News Staff
Updated 9:06 AM CDT, Thu May 30, 2024
MELBOURNE, Fla. – Smart seating startup Kalogon has raised $1.2 million in extended seed funding to expand its line of products. The company will use the funds to bolster R&D and go-to-market following a standout year of product advancements and record sales that included partnerships with mobility device distributors – such as Etac and National Seating & Mobility – and the completion of the AgeTech Collaborative from AARP’s accelerator program. “This funding is validation for the hard work and tangible results driven by our team in the last year,” said Tim Balz, founder and CEO of Kalogon. “With our relentless pursuit of science-backed innovation and an unwavering dedication to the user experience, we are ushering in a new future for seated wellness. The partnerships and product developments we have achieved recently have opened new doors, and this round will help us further expand our offerings and availability in the market.” Sawmill Angels, M7, SeedFundersOrlando, AARP and additional angels participated in the oversubscribed seed extension. Kalogon also recently completed a Phase 1 SBIR contract with the U.S. Air Force and published research in the Journal of Tissue Viability that demonstrated the efficacy of Kalogon’s APM system. Additionally, the company recently announced its first Medicare-approved wheelchair cushion – OrbiterTM Med – increasing its market by 10x and accelerating reimbursement for medical use.
Comments